Loading chat...
MN SF2218
Bill
Status
Introduced
3/22/2021
Primary Sponsor
Erin Murphy
Click for details
AI Summary
-
Health plans must limit co-payments for prescription drugs treating chronic diseases to $25 per one-month supply, including related medical supplies needed to administer the drugs
-
Chronic diseases covered under this requirement are diabetes, asthma, and allergies requiring epinephrine auto-injectors
-
The requirement applies to health plans offered, issued, and renewed on or after January 1, 2022
-
Creates new statute Minnesota Statutes, chapter 62Q.481
Legislative Description
Co-payment limit for prescription drugs treating chronic disease
Last Action
Author added Abeler
3/24/2022
Committee Referrals
Health and Human Services Finance and Policy3/22/2021
Full Bill Text
No bill text available